z-logo
open-access-imgOpen Access
Advances in diagnosis and treatment of eosinophilia
Author(s) -
Javed Sheikh,
Peter F. Weller
Publication year - 2008
Publication title -
current opinion in hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 97
eISSN - 1080-8213
pISSN - 1065-6251
DOI - 10.1097/moh.0b013e32831c841f
Subject(s) - hypereosinophilia , hypereosinophilic syndrome , eosinophil , immunology , eosinophilia , population , biology , myeloproliferative disorders , medicine , pathology , environmental health , asthma
Hypereosinophilic syndromes (HESs) are disorders characterized by sustained blood or tissue hypereosinophilia or both with subsequent damage to various organs due to eosinophilic infiltration and release of mediators. HES are now recognized to include varied eosinophilic disorders for some of which there are recent insights into their pathogenesis and targeted treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom